1 min read
Add as a preferred source on Google

Nasus Pharma Names Nir Sassi Chief Financial Officer Effective Nov. 11

Sassi most recently served as CFO of Indaptus Therapeutics and previously held the role at Intec Pharma.

An executive enters a quiet office through a glass doorway / TokenPost.ai
An executive enters a quiet office through a glass doorway / TokenPost.ai

Nasus Pharma Ltd. appointed Nir Sassi as chief financial officer effective Nov. 11, the company announced Monday. Its shares trade on the New York Stock Exchange under the ticker NSRX.

Sassi most recently served as CFO of Indaptus Therapeutics. He previously held the same role at Intec Pharma.

Sonny Jang

Reporter

Sonny Jang reports on people and leadership in digital assets for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…